Adamis Pharmaceuticals

$0.75
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0086 (-1.17%) Today
+$0.021 (+2.88%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ADMP and other stocks, options, and ETFs commission-free!

About ADMP

Adamis Pharmaceuticals Corporation Common Stock, also called Adamis Pharmaceuticals, is a biopharmaceutical company, which engages in the discovery, development and sales of pharmaceutical, specialty biopharmaceutical and other drug products. It offers Symjepi product for allergy, respiratory, opioid overdose, and erectile dysfuncti markets.

CEO
Dennis J. Carlo
Employees
171
Headquarters
San Diego, California
Founded
2006
Market Cap
107.64M
Price-Earnings Ratio
Dividend Yield
Average Volume
3.25M
High Today
$0.7582
Low Today
$0.6901
Open Price
$0.74
Volume
3.86M
52 Week High
$2.34
52 Week Low
$0.3163

ADMP Earnings

-$0.24
-$0.16
-$0.08
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
per share
Actual
Expected May 17, After Hours
Replay Earnings Call

You May Also Like

KCE
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure